drugset / Trial / NCT01324323
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the effect and safety of multiple doses of rifampin on the pharmacokinetics of romidepsin after a single intravenous (IV) infusion.
Timeline
- Start
- 2011-04-01
- Primary completion
- 2012-02-01
- Completion
- 2012-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifampin | Small molecule | 600 mg | Oral |
| Subject | Romidepsin | Peptide | 14 mg/m2 | Intravenous |